Citations (19)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Akie Hirata, Kaname Miyashita, Takafumi Tanaka, Kiyoko Hirata, Taisuke Narazaki, Hayato Utsunomiya, Hirofumi Ohno, Eriko Nakashima, Yoshimichi Tachikawa, Ilseung Choi, Kenichi Taguchi & Youko Suehiro. (2022) Serum immunoglobulin G as a discriminator of infection in follicular lymphoma patients undergoing chemotherapy with bendamustine in combination with rituximab. Hematology 27:1, pages 384-395.
Read now
Read now
Anat Gafter-Gvili & Aaron Polliack. (2016) Bendamustine associated immune suppression and infections during therapy of hematological malignancies. Leukemia & Lymphoma 57:3, pages 512-519.
Read now
Read now
Martin Dreyling & Marion Subklewe. (2015) Bendamustine and the immune system: a wolf in sheep's clothing?. Leukemia & Lymphoma 56:4, pages 837-838.
Read now
Read now
Articles from other publishers (16)
Yoshikazu Ikoma, Nobuhiko Nakamura, Junichi Kitagawa, Takao Miwa, Eri Takada, Takuro Matsumoto, Yuhei Shibata, Hiroshi Nakamura, Nobuhiro Kanemura, Senji Kasahara, Takeshi Hara, Michio Sawada, Hisashi Tsurumi & Masahito Shimizu. (2023) A phase II study of gemcitabine, carboplatin, dexamethasone, and rituximab in patients with relapsed or refractory non‐Hodgkin lymphoma. Hematological Oncology.
Crossref
Crossref
Yu Yagi, Yusuke Kanemasa, Yuki Sasaki, Mina Sei, Takuma Matsuo, Kento Ishimine, Yudai Hayashi, Mano Mino, An Ohigashi, Yuka Morita, Taichi Tamura, Shohei Nakamura, Toshihiro Okuya, Takuya Shimizuguchi, Naoki Shingai, Takashi Toya, Hiroaki Shimizu, Yuho Najima, Takeshi Kobayashi, Kyoko Haraguchi, Noriko Doki, Yoshiki Okuyama & Tatsu Shimoyama. (2023) Clinical outcomes in transplant‐eligible patients with relapsed or refractory diffuse large B‐cell lymphoma after second‐line salvage chemotherapy: A retrospective study. Cancer Medicine.
Crossref
Crossref
Montserrat Torres, Magdalena Corona, Sara Rodríguez-Mora, Guiomar Casado-Fernández, Alejandro Zurdo-Castronuño, Elena Mateos, Fernando Ramos-Martín, Clara Sánchez-Menéndez, María Aranzazú Murciano-Antón, Javier García-Pérez, José Alcamí, Mayte Pérez-Olmeda, Mayte Coiras, Javier López-Jiménez & Valentín García-Gutiérrez. (2022) Strong Humoral but Not Cellular Immune Responses against SARS-CoV-2 in Individuals with Oncohematological Disease Who Were Treated with Rituximab before Receiving a Vaccine Booster. Cancers 14:22, pages 5537.
Crossref
Crossref
Manabu SuzukiDaisuke KoyamaShohei IkedaMasumi SukegawaMayumi TeshirogiKyohei Misawa & Saburo Tsunoda. (2022) Serum IgG and lymphocyte counts are useful for the early detection of infection in patients receiving bendamustine-rituximab therapy. Journal of Clinical and Experimental Hematopathology 62:2, pages 91-98.
Crossref
Crossref
Luca Pezzullo, Valentina Giudice, Bianca Serio, Raffaele Fontana, Roberto Guariglia, Maria Carmen Martorelli, Idalucia Ferrara, Laura Mettivier, Alessandro Bruno, Rosario Bianco, Emilia Vaccaro, Pasquale Pagliano, Nunzia Montuori, Amelia Filippelli & Carmine Selleri. (2021) Real-world evidence of cytomegalovirus reactivation in non-Hodgkin lymphomas treated with bendamustine-containing regimens. Open Medicine 16:1, pages 672-682.
Crossref
Crossref
Tania Jain, Merav Bar, Ankit J. Kansagra, Elise A. Chong, Shahrukh K. Hashmi, Sattva S. Neelapu, Michael Byrne, Elad Jacoby, Aleksandr Lazaryan, Caron A. Jacobson, Stephen M. Ansell, Farrukh T. Awan, Linda Burns, Veronika Bachanova, Catherine M. Bollard, Paul A. Carpenter, John F. DiPersio, Mehdi Hamadani, Helen E. Heslop, Joshua A. Hill, Krishna V. Komanduri, Craig A. Kovitz, Hillard M. Lazarus, Justin M. Serrette, Mohamad Mohty, David Miklos, Arnon Nagler, Steven Z. Pavletic, Bipin N. Savani, Stephen J. Schuster, Mohamed A. Kharfan-Dabaja, Miguel-Angel Perales & Yi Lin. (2019) Use of Chimeric Antigen Receptor T Cell Therapy in Clinical Practice for Relapsed/Refractory Aggressive B Cell Non-Hodgkin Lymphoma: An Expert Panel Opinion from the American Society for Transplantation and Cellular Therapy. Biology of Blood and Marrow Transplantation 25:12, pages 2305-2321.
Crossref
Crossref
Nicolás Martínez‐Calle, Sarah Hartley, Matthew Ahearne, Benjamin Kasenda, Amy Beech, Helen Knight, Constantine Balotis, Ben Kennedy, Simon Wagner, Martin J. S. Dyer, Dean Smith, Andrew K. McMillan, Fiona Miall, Mark Bishton & Christopher P. Fox. (2018) Kinetics of T‐cell subset reconstitution following treatment with bendamustine and rituximab for low‐grade lymphoproliferative disease: a population‐based analysis. British Journal of Haematology 184:6, pages 957-968.
Crossref
Crossref
Wolfgang HiddemannAnna Maria BarbuiMiguel A. CanalesPaul K. CannellGraham P. CollinsJan DürigRoswitha ForstpointnerMichael HeroldMark HertzbergMagdalena KlanovaJohn RadfordJohn F. SeymourKensei TobinaiJudith TrotmanAlis BurciuGünter Fingerle-RowsonMarcel WolbersTina NielsenRobert E. Marcus. (2018) Immunochemotherapy With Obinutuzumab or Rituximab for Previously Untreated Follicular Lymphoma in the GALLIUM Study: Influence of Chemotherapy on Efficacy and Safety. Journal of Clinical Oncology 36:23, pages 2395-2404.
Crossref
Crossref
Yueyan Huang, Manxiang Yin, Linlin Pan, Qian Yu, Qifeng Zhu, Weizhen Xu, Baoyue Ding, Yanping Ji & Jifang Zhou. (2018) Solanum nigrum polysaccharide inhibits tumor growth in H22-bearing mice through regulation of caspase-3 and bcl-2. Journal of Cancer Research and Therapeutics 14:Suppl 1, pages S232-S236.
Crossref
Crossref
Anat Gafter-Gvili, Ronit Gurion, Pia Raanani, Ofer Shpilberg & Liat Vidal. (2017) Bendamustine-associated infections-systematic review and meta-analysis of randomized controlled trials. Hematological Oncology 35:4, pages 424-431.
Crossref
Crossref
I F Khouri, D Sui, E J Jabbour, B I Samuels, F Turturro, G Alatrash, P Anderlini, S Ahmed, B Oran, S O Ciurea, D Marin, A Olson, K K Patel, U R Popat, C Ledesma, T M Kadia, A Ferrajoli, J A Burger, J L Jorgensen, L J Medeiros, R L Bassett & A M Gulbis. (2016) Bendamustine added to allogeneic conditioning improves long-term outcomes in patients with CLL. Bone Marrow Transplantation 52:1, pages 28-33.
Crossref
Crossref
. (2016) Bendamustine/rituximab. Reactions Weekly 1603:1, pages 43-43.
Crossref
Crossref
Jeonghoon HaYunhwa JungYunduk JungSanbin LeeYoonseo LeeInsook Woo. (2016)
A case of
Pneumocystis jiroveci
pneumonia after bendamustine-based chemotherapy for refractory diffuse large B-cell lymphoma
. Blood Research 51:1, pages 61.
Crossref
Crossref
Kaori Ito, Masataka Okamoto, Yoko Inaguma, Akinao Okamoto, Maiko Ando, Yosuke Ando, Masahiro Tsuge, Ayana Tomono, Yukiko Kakumae, Takahiro Hayashi, Shigeki Yamada & Nobuhiko Emi. (2016) Influence of R-CHOP Therapy on Immune System Restoration in Patients with B-Cell Lymphoma. Oncology 91:6, pages 302-310.
Crossref
Crossref
Federico De Angelis, Maria Elena Tosti, Saveria Capria, Eleonora Russo, Gianna Maria D’Elia, Giorgia Annechini, Caterina Stefanizzi, Robin Foà & Alessandro Pulsoni. (2015) Risk of secondary hypogammaglobulinaemia after Rituximab and Fludarabine in indolent non-Hodgkin lymphomas: A retrospective cohort study. Leukemia Research 39:12, pages 1382-1388.
Crossref
Crossref
Kristy L. Richards & Steven E. Suter. (2014)
Man's best friend: what can pet dogs teach us about non‐
H
odgkin's lymphoma?
. Immunological Reviews 263:1, pages 173-191.
Crossref
Crossref